Geode Capital Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $125M | Buy |
|
|||||
|
2025
Q2 | $80.9M | Buy |
|
|||||
|
2025
Q1 | $81.4M | Sell |
|
|||||
|
2024
Q4 | $82.8M | Buy |
|
|||||
|
2024
Q3 | $119M | Buy |
|
|||||
|
2024
Q2 | $92.2M | Buy |
|
|||||
|
2024
Q1 | $40.8M | Buy |
|
|||||
|
2023
Q4 | $14M | Buy |
|
|||||
|
2023
Q3 | $9.16M | Sell |
|
|||||
|
2023
Q2 | $16M | Buy |
|
|||||
|
2023
Q1 | $20M | Buy |
|
|||||
|
2022
Q4 | $24.9M | Buy |
|
|||||
|
2022
Q3 | $15.3M | Buy |
|
|||||
|
2022
Q2 | $12.3M | Buy |
|
|||||
|
2022
Q1 | $13.6M | Buy |
|
|||||
|
2021
Q4 | $17M | Sell |
|
|||||
|
2021
Q3 | $18.2M | Buy |
|
|||||
|
2021
Q2 | $10.2M | Buy |
|
|||||
|
2021
Q1 | $8.85M | Buy |
|
|||||
|
2020
Q4 | $6.78M | Sell |
|
|||||
|
2020
Q3 | $7.62M | Buy |
|
|||||
|
2020
Q2 | $478K | Buy |
|